Related Experiment Video
Updated: Jul 13, 2025

ROS Live Cell Imaging During Neuronal Development
Published on: February 9, 2021
NOX-induced oxidative stress is a primary trigger of major neurodegenerative disorders
Yuri Zilberter1, Dennis R Tabuena2, Misha Zilberter2
1Aix-Marseille Université, INSERM UMR1106, Institut de Neurosciences des Systèmes, Marseille, France.
Abstract:
Neurodegenerative diseases (NDDs) causing cognitive impairment and dementia are difficult to treat due to the lack of understanding of primary initiating factors. Meanwhile, major sporadic NDDs share many risk factors and exhibit similar pathologies in their early stages, indicating the existence of common initiation pathways. Glucose hypometabolism associated with oxidative stress is one such primary, early and shared pathology, and a likely major cause of detrimental disease-associated cascades; targeting this common pathology may therefore be an effective preventative strategy for most sporadic NDDs. However, its exact cause and trigger remain unclear. Recent research suggests that early oxidative stress caused by NADPH oxidase (NOX) activation is a shared initiating mechanism among major sporadic NDDs and could prove to be the long-sought ubiquitous NDD trigger. We focus on two major NDDs - Alzheimer's disease (AD) and Parkinson's disease (PD), as well as on acquired epilepsy which is an increasingly recognized comorbidity in NDDs. We also discuss available data suggesting the relevance of the proposed mechanisms to other NDDs. We delve into the commonalities among these NDDs in neuroinflammation and NOX involvement to identify potential therapeutic targets and gain a deeper understanding of the underlying causes of NDDs.
Insights
Oxidative stress from NADPH oxidase (NOX) activation may be a common trigger for neurodegenerative diseases (NDDs). Targeting this early oxidative stress could offer a preventative strategy for conditions like Alzheimer's and Parkinson's disease.
Area of Science:
- Neuroscience
- Pathology
- Biochemistry
Background:
- Neurodegenerative diseases (NDDs) present significant treatment challenges due to poorly understood initiating factors.
- Shared risk factors and early pathologies in major sporadic NDDs suggest common initiation pathways.
- Glucose hypometabolism and oxidative stress are early, shared pathologies implicated in NDDs.
Purpose of the Study:
- To investigate NADPH oxidase (NOX) activation as a potential ubiquitous trigger for sporadic NDDs.
- To explore commonalities in neuroinflammation and NOX involvement across Alzheimer's disease (AD), Parkinson's disease (PD), and epilepsy.
- To identify potential therapeutic targets for NDDs by understanding shared initiating mechanisms.
Main Methods:
- Review of recent research on oxidative stress and NDDs.
- Analysis of commonalities in neuroinflammation and NOX pathways in AD, PD, and epilepsy.
- Discussion of data supporting the proposed mechanisms in other NDDs.
Main Results:
- NADPH oxidase (NOX) activation leading to early oxidative stress is proposed as a shared initiating mechanism in major sporadic NDDs.
- Glucose hypometabolism and oxidative stress are identified as primary, early pathologies.
- Neuroinflammation and NOX involvement are common features across studied NDDs.
Conclusions:
- Targeting early oxidative stress caused by NOX activation may be a viable preventative strategy for multiple sporadic NDDs.
- Understanding shared pathways like neuroinflammation and NOX activation is crucial for developing effective NDD therapeutics.
- This research provides a framework for investigating a common trigger for diverse neurodegenerative conditions.
More Related Videos
Related Concept Videos
Disorders of the Nervous Tissue
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises from the...
Parkinson's Disease: Overview
Aging
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
Drugs Affecting Neurotransmitter Synthesis
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Excitatory and Inhibitory Effects of Neurotransmitters

